Below ive linked a few videos and articles that show the company in a medias light.
http://www.biotron.com.au/wp-content/uploads/2013/04/2013_Mar_Cosmos_Perilous-Journey.pdf
The current issue that biotron is having is funding and also the results to clear the clinical trials as a success
Hi Declan, I can't seem to find a link to your company's annual report so I have not had the chance to take a look at it. However, from what you have discussed companies like Biotron spend a lot of money of R & D which they must expense as according to the accounting standards, it cannot be capitalised until such time that it is probable that future economic benefits will flow from such a product. From the Sky video information, if this drug proves to be successful then they will definitely be a first mover in the market. As noted they are almost at phase 3 with this drug and will certainly be looking for a licence or a partner with very deep pockets, i.e.., a large pharmaceutical as it takes a lot of time and money to get new drugs approved in any market. Unfortunately from what you have noted in your blog, the shareholders' patience seems to be wearing thin. I look forward to having more discussions with you and comparing our companies as my company is very similar to yours - it only reports a loss and relies of selling securities to finance its activities. Here's the link to my blog: raehorton.blogspot.com.au
ReplyDeleteCheers, Rae